Ran, S.; Yang, J.; Hu, J.; Fang, L.; He, W.
Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients. Curr. Oncol. 2023, 30, 10166-10178.
https://doi.org/10.3390/curroncol30120740
AMA Style
Ran S, Yang J, Hu J, Fang L, He W.
Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients. Current Oncology. 2023; 30(12):10166-10178.
https://doi.org/10.3390/curroncol30120740
Chicago/Turabian Style
Ran, Shengming, Jingtian Yang, Jintao Hu, Liekui Fang, and Wang He.
2023. "Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients" Current Oncology 30, no. 12: 10166-10178.
https://doi.org/10.3390/curroncol30120740
APA Style
Ran, S., Yang, J., Hu, J., Fang, L., & He, W.
(2023). Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients. Current Oncology, 30(12), 10166-10178.
https://doi.org/10.3390/curroncol30120740